JP2011500858A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011500858A5 JP2011500858A5 JP2010531412A JP2010531412A JP2011500858A5 JP 2011500858 A5 JP2011500858 A5 JP 2011500858A5 JP 2010531412 A JP2010531412 A JP 2010531412A JP 2010531412 A JP2010531412 A JP 2010531412A JP 2011500858 A5 JP2011500858 A5 JP 2011500858A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- mir
- cell
- antisense molecule
- expression
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 108091059456 miR-92-1 stem-loop Proteins 0.000 claims 18
- 108091084336 miR-92-2 stem-loop Proteins 0.000 claims 18
- 210000004027 cell Anatomy 0.000 claims 13
- 230000000692 anti-sense effect Effects 0.000 claims 12
- 201000001320 Atherosclerosis Diseases 0.000 claims 4
- 239000004480 active ingredient Substances 0.000 claims 4
- 230000033115 angiogenesis Effects 0.000 claims 4
- 201000010099 disease Diseases 0.000 claims 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 4
- 239000002773 nucleotide Substances 0.000 claims 4
- 125000003729 nucleotide group Chemical group 0.000 claims 4
- 239000008194 pharmaceutical composition Substances 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 3
- 230000002792 vascular Effects 0.000 claims 3
- 208000034038 Pathologic Neovascularization Diseases 0.000 claims 2
- 239000003795 chemical substances by application Substances 0.000 claims 2
- 230000000694 effects Effects 0.000 claims 2
- 208000028867 ischemia Diseases 0.000 claims 2
- 208000037921 secondary disease Diseases 0.000 claims 2
- 210000000130 stem cell Anatomy 0.000 claims 2
- 229940124597 therapeutic agent Drugs 0.000 claims 2
- 230000005747 tumor angiogenesis Effects 0.000 claims 2
- 241000124008 Mammalia Species 0.000 claims 1
- 241001465754 Metazoa Species 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 210000004413 cardiac myocyte Anatomy 0.000 claims 1
- 208000037976 chronic inflammation Diseases 0.000 claims 1
- 230000006020 chronic inflammation Effects 0.000 claims 1
- 230000000295 complement effect Effects 0.000 claims 1
- 230000007423 decrease Effects 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 210000001671 embryonic stem cell Anatomy 0.000 claims 1
- 210000003958 hematopoietic stem cell Anatomy 0.000 claims 1
- 210000004969 inflammatory cell Anatomy 0.000 claims 1
- 239000003112 inhibitor Substances 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 108091070501 miRNA Proteins 0.000 claims 1
- 210000002569 neuron Anatomy 0.000 claims 1
- 210000005167 vascular cell Anatomy 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102007052114A DE102007052114B4 (de) | 2007-10-30 | 2007-10-30 | Verfahren zur Modulation der Funktion, des Wachstums oder der Differenzierung einer Zelle |
| DE102007052114.8 | 2007-10-30 | ||
| PCT/DE2008/001759 WO2009056116A1 (de) | 2007-10-30 | 2008-10-30 | Verfahren zur förderung der angiogenese, vaskularisierung oder gefässreparatur oder zur hemmung der tumorangiogenese |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014116545A Division JP2014196317A (ja) | 2007-10-30 | 2014-06-05 | 血管新生、血管形成、若しくは血管修復を促進するか、又は腫瘍血管新生を阻害する方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011500858A JP2011500858A (ja) | 2011-01-06 |
| JP2011500858A5 true JP2011500858A5 (OSRAM) | 2012-12-13 |
| JP5898843B2 JP5898843B2 (ja) | 2016-04-06 |
Family
ID=40375407
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010531412A Expired - Fee Related JP5898843B2 (ja) | 2007-10-30 | 2008-10-30 | 血管新生、血管形成、若しくは血管修復を促進するか、又は腫瘍血管新生を阻害する方法 |
| JP2014116545A Pending JP2014196317A (ja) | 2007-10-30 | 2014-06-05 | 血管新生、血管形成、若しくは血管修復を促進するか、又は腫瘍血管新生を阻害する方法 |
| JP2016125260A Pending JP2016199565A (ja) | 2007-10-30 | 2016-06-24 | 血管新生、血管形成、若しくは血管修復を促進するか、又は腫瘍血管新生を阻害する方法 |
| JP2017239230A Pending JP2018083817A (ja) | 2007-10-30 | 2017-12-14 | 血管新生、血管形成、若しくは血管修復を促進するか、又は腫瘍血管新生を阻害する方法 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2014116545A Pending JP2014196317A (ja) | 2007-10-30 | 2014-06-05 | 血管新生、血管形成、若しくは血管修復を促進するか、又は腫瘍血管新生を阻害する方法 |
| JP2016125260A Pending JP2016199565A (ja) | 2007-10-30 | 2016-06-24 | 血管新生、血管形成、若しくは血管修復を促進するか、又は腫瘍血管新生を阻害する方法 |
| JP2017239230A Pending JP2018083817A (ja) | 2007-10-30 | 2017-12-14 | 血管新生、血管形成、若しくは血管修復を促進するか、又は腫瘍血管新生を阻害する方法 |
Country Status (16)
| Country | Link |
|---|---|
| US (4) | US8258113B2 (OSRAM) |
| EP (3) | EP2684956B1 (OSRAM) |
| JP (4) | JP5898843B2 (OSRAM) |
| CA (1) | CA2704290C (OSRAM) |
| CY (2) | CY1120360T1 (OSRAM) |
| DE (1) | DE102007052114B4 (OSRAM) |
| DK (2) | DK2684955T3 (OSRAM) |
| ES (2) | ES2651287T3 (OSRAM) |
| HR (2) | HRP20170346T1 (OSRAM) |
| HU (2) | HUE037494T2 (OSRAM) |
| LT (2) | LT2684955T (OSRAM) |
| NO (1) | NO2684955T3 (OSRAM) |
| PL (2) | PL2217704T3 (OSRAM) |
| PT (2) | PT2684955T (OSRAM) |
| SI (2) | SI2217704T1 (OSRAM) |
| WO (1) | WO2009056116A1 (OSRAM) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITRM20030376A1 (it) | 2003-07-31 | 2005-02-01 | Univ Roma | Procedimento per l'isolamento e l'espansione di cellule staminali cardiache da biopsia. |
| US11660317B2 (en) | 2004-11-08 | 2023-05-30 | The Johns Hopkins University | Compositions comprising cardiosphere-derived cells for use in cell therapy |
| HUE037173T2 (hu) | 2006-08-08 | 2018-08-28 | Univ Bonn Rheinische Friedrich Wilhelms | 5'-Foszfát-oligonukleotidok szerkezete és alkalmazása |
| DE102007052114B4 (de) | 2007-10-30 | 2011-01-05 | T2Cure Gmbh | Verfahren zur Modulation der Funktion, des Wachstums oder der Differenzierung einer Zelle |
| US9738680B2 (en) | 2008-05-21 | 2017-08-22 | Rheinische Friedrich-Wilhelms-Universität Bonn | 5′ triphosphate oligonucleotide with blunt end and uses thereof |
| US9249392B2 (en) | 2010-04-30 | 2016-02-02 | Cedars-Sinai Medical Center | Methods and compositions for maintaining genomic stability in cultured stem cells |
| US9845457B2 (en) | 2010-04-30 | 2017-12-19 | Cedars-Sinai Medical Center | Maintenance of genomic stability in cultured stem cells |
| WO2012065024A1 (en) * | 2010-11-11 | 2012-05-18 | University Of Miami | Compositions, cells, kits and methods for autologous stem cell therapy |
| EP2508530A1 (en) | 2011-03-28 | 2012-10-10 | Rheinische Friedrich-Wilhelms-Universität Bonn | Purification of triphosphorylated oligonucleotides using capture tags |
| US9884076B2 (en) | 2012-06-05 | 2018-02-06 | Capricor, Inc. | Optimized methods for generation of cardiac stem cells from cardiac tissue and their use in cardiac therapy |
| CN104685056A (zh) | 2012-06-21 | 2015-06-03 | 米拉根医疗股份有限公司 | 包含锁核酸基序的基于寡核苷酸的抑制剂 |
| EP2882445B1 (en) | 2012-08-13 | 2019-04-24 | Cedars-Sinai Medical Center | Exosomes and micro-ribonucleic acids for tissue regeneration |
| EP2712870A1 (en) | 2012-09-27 | 2014-04-02 | Rheinische Friedrich-Wilhelms-Universität Bonn | Novel RIG-I ligands and methods for producing them |
| EP2759595B1 (en) * | 2013-01-24 | 2016-09-14 | Pierre Fabre Médicament S.A.S. | Composition comprising an encapsulated antagomir |
| WO2014145356A1 (en) | 2013-03-15 | 2014-09-18 | MiRagen Therapeutics, Inc. | Bridged bicyclic nucleosides |
| US11253549B2 (en) | 2014-05-23 | 2022-02-22 | JangoBio, LLC | Methods to rebalance the hypothalamic-pituitary-gonadal axis |
| US11439668B2 (en) | 2014-05-23 | 2022-09-13 | JangoBio, LLC | Methods to differentiate stem cells into hormone-producing cells |
| CA2962444C (en) | 2014-10-03 | 2023-09-05 | Cedars-Sinai Medical Center | Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of muscular dystrophy |
| US20160122762A1 (en) * | 2014-10-27 | 2016-05-05 | University Of Iowa Research Foundation | Methods of treating atherosclerosis |
| HK1249108A1 (zh) * | 2015-01-20 | 2018-10-26 | 米拉根医疗股份有限公司 | Mir-92抑制剂及其用途 |
| WO2017123662A1 (en) | 2016-01-11 | 2017-07-20 | Cedars-Sinai Medical Center | Cardiosphere-derived cells and exosomes secreted by such cells in the treatment of heart failure with preserved ejection fraction |
| US11351200B2 (en) | 2016-06-03 | 2022-06-07 | Cedars-Sinai Medical Center | CDC-derived exosomes for treatment of ventricular tachyarrythmias |
| CN107586784B (zh) * | 2016-07-08 | 2020-08-25 | 田小利 | 一种分离的rnasek基因及其在制备抗血管衰老药物中的应用 |
| EP3515459A4 (en) | 2016-09-20 | 2020-08-05 | Cedars-Sinai Medical Center | CELLS DERIVED FROM CARDIOSPHERES AND THEIR EXTRACELLULAR VESICLES TO DELAY OR REVERSE AGING AND AGE-RELATED DISORDERS |
| US11759482B2 (en) | 2017-04-19 | 2023-09-19 | Cedars-Sinai Medical Center | Methods and compositions for treating skeletal muscular dystrophy |
| US11660355B2 (en) | 2017-12-20 | 2023-05-30 | Cedars-Sinai Medical Center | Engineered extracellular vesicles for enhanced tissue delivery |
| EP3749344A4 (en) | 2018-02-05 | 2022-01-26 | Cedars-Sinai Medical Center | METHODS OF THERAPEUTIC USE OF EXOSOMES AND Y-RNAS |
| WO2019167995A1 (ja) * | 2018-02-28 | 2019-09-06 | 国立大学法人東京医科歯科大学 | 虚血病変部位特異的な遺伝子治療法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1648914A4 (en) * | 2003-07-31 | 2009-12-16 | Regulus Therapeutics Inc | OLIGOMERIC COMPOUNDS AND COMPOSITIONS USEFUL FOR MODULATING SMALL NON-CODING RNA |
| AU2005250432B2 (en) * | 2004-05-28 | 2011-09-15 | Asuragen, Inc. | Methods and compositions involving microRNA |
| EP1904111A4 (en) * | 2005-06-03 | 2009-08-19 | Univ Johns Hopkins | COMPOSITIONS AND METHODS FOR REDUCING MICRORNA EXPRESSION FOR THE TREATMENT OF NEOPLASIA |
| EP2455492B1 (en) * | 2006-07-13 | 2013-11-20 | The Ohio State University Research Foundation | Micro-RNA-based methods and compositions for the diagnosis and treatment of colon related diseases |
| US8466117B2 (en) * | 2006-07-28 | 2013-06-18 | The Johns Hopkins University | Compositions and methods for modulating angiogenesis |
| WO2008070082A2 (en) * | 2006-12-04 | 2008-06-12 | The Johns Hopkins University | Stem-progenitor cell specific micro-ribonucleic acids and uses thereof |
| WO2009004632A2 (en) * | 2007-07-05 | 2009-01-08 | Yeda Research And Development Co. Ltd. | Methods of identifying components of a biological pathway and use of said components in regulating diseases associated with altered cell proliferation |
| WO2009012468A2 (en) * | 2007-07-18 | 2009-01-22 | The Regents Of The University Colorado | Differential expression of micrornas in nonfailing versus failing human hearts |
| DE102007052114B4 (de) | 2007-10-30 | 2011-01-05 | T2Cure Gmbh | Verfahren zur Modulation der Funktion, des Wachstums oder der Differenzierung einer Zelle |
-
2007
- 2007-10-30 DE DE102007052114A patent/DE102007052114B4/de active Active
-
2008
- 2008-10-30 PT PT131791444T patent/PT2684955T/pt unknown
- 2008-10-30 ES ES13179144.4T patent/ES2651287T3/es active Active
- 2008-10-30 NO NO13179144A patent/NO2684955T3/no unknown
- 2008-10-30 US US12/739,876 patent/US8258113B2/en active Active
- 2008-10-30 EP EP13179146.9A patent/EP2684956B1/de active Active
- 2008-10-30 EP EP08844273.6A patent/EP2217704B1/de active Active
- 2008-10-30 CA CA2704290A patent/CA2704290C/en not_active Expired - Fee Related
- 2008-10-30 PL PL08844273T patent/PL2217704T3/pl unknown
- 2008-10-30 PT PT88442736T patent/PT2217704T/pt unknown
- 2008-10-30 JP JP2010531412A patent/JP5898843B2/ja not_active Expired - Fee Related
- 2008-10-30 WO PCT/DE2008/001759 patent/WO2009056116A1/de not_active Ceased
- 2008-10-30 PL PL13179144T patent/PL2684955T3/pl unknown
- 2008-10-30 DK DK13179144.4T patent/DK2684955T3/en active
- 2008-10-30 DK DK08844273.6T patent/DK2217704T3/en active
- 2008-10-30 HU HUE13179144A patent/HUE037494T2/hu unknown
- 2008-10-30 EP EP13179144.4A patent/EP2684955B1/de active Active
- 2008-10-30 HR HRP20170346TT patent/HRP20170346T1/hr unknown
- 2008-10-30 SI SI200831774A patent/SI2217704T1/sl unknown
- 2008-10-30 SI SI200831894T patent/SI2684955T1/en unknown
- 2008-10-30 LT LTEP13179144.4T patent/LT2684955T/lt unknown
- 2008-10-30 HU HUE08844273A patent/HUE031559T2/hu unknown
- 2008-10-30 LT LTEP08844273.6T patent/LT2217704T/lt unknown
- 2008-10-30 ES ES08844273.6T patent/ES2618203T3/es active Active
-
2012
- 2012-08-08 US US13/569,786 patent/US8912158B2/en active Active
-
2014
- 2014-06-05 JP JP2014116545A patent/JP2014196317A/ja active Pending
- 2014-07-31 US US14/448,119 patent/US9279123B2/en active Active
-
2016
- 2016-02-10 US US15/040,487 patent/US9862949B2/en active Active
- 2016-06-24 JP JP2016125260A patent/JP2016199565A/ja active Pending
-
2017
- 2017-02-22 CY CY20171100245T patent/CY1120360T1/el unknown
- 2017-12-04 HR HRP20171874TT patent/HRP20171874T1/hr unknown
- 2017-12-06 CY CY20171101283T patent/CY1120226T1/el unknown
- 2017-12-14 JP JP2017239230A patent/JP2018083817A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011500858A5 (OSRAM) | ||
| Madhyastha et al. | MicroRNA signature in diabetic wound healing: promotive role of miR‐21 in fibroblast migration | |
| JP2009219504A5 (OSRAM) | ||
| ES2852998T3 (es) | Oligonucleótidos para inducir la expresión de UBE3A paterno | |
| Sen et al. | Micromanaging vascular biology: tiny microRNAs play big band | |
| US20200155606A1 (en) | Crispr/rna-guided nuclease systems and methods | |
| US10159670B2 (en) | Methods of diagnosing and treating motor neuron diseases and other cellular stress-related diseases | |
| JP2022081503A (ja) | ＣＲＩＳＰＲ／Ｃａｓ９の核送達を通じた細胞ＲＮＡの追跡と操作 | |
| US20200157515A1 (en) | Systems and methods for the treatment of hemoglobinopathies | |
| EP3128008B1 (en) | Double-stranded oligo rna and pharmaceutical composition comprising same for preventing or treating fibrosis or respiratory diseases | |
| Piccoli et al. | Non-coding RNAs as modulators of the cardiac fibroblast phenotype | |
| JP2014527401A5 (OSRAM) | ||
| JP2016513976A5 (OSRAM) | ||
| JP2017093448A5 (OSRAM) | ||
| JP2011522036A5 (OSRAM) | ||
| JP2015502365A5 (OSRAM) | ||
| CA2968336A1 (en) | Construct for site directed editing of an adenosine nucleotide in target rna | |
| JP2012130342A5 (OSRAM) | ||
| JP2010530239A5 (OSRAM) | ||
| NZ597071A (en) | Compositions and methods for modulation of smn2 splicing in a subject | |
| RU2020104969A (ru) | Способы и продукты для получения и доставки нуклеиновых кислот | |
| Frost et al. | miRNAs as therapeutic targets in ischemic heart disease | |
| BR112020007417A2 (pt) | molécula de ácido nucleico para redução de papd5 e papd7 de mrna para o tratamento de infecção hepatite b | |
| JP2020511116A (ja) | 体細胞を誘導血管性細胞にリプログラミングするための組成物および方法 | |
| JP7499267B2 (ja) | Ａｔｘｎ２発現を調節するためのオリゴヌクレオチド |